$8.3Bn Coronavirus Response Act Lays Out US FDA’s, CDC’s And Localities’ Roles In Fighting Virus
Executive Summary
An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.
You may also be interested in...
US COVID-19 Testing Costs Covered By 2nd Coronavirus Response Act; Third $1Tn Relief Bill Coming
The US Congress wrapped up work on 18 March on a second COVID-19 preparedness bill to cover costs of testing uninsured individuals, military beneficiaries and other outbreak responses. A planned third COVID-19 relief package would dole out $1tn to agencies and device makers.
COVID-19 Fact File: Global Diagnostic Test Pipeline
Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.
US Hospitals Cancel Elective Surgeries, Team Up With Medtechs To Find Remote-Monitoring Solutions
US health systems are canceling elective surgeries in response to COVID-19 to preserve critical resources. Massachusetts General Hospital works with medtechs to find technological solutions to keep patients and caregivers safe.